Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4301
CBAK Energy Technology Ltd
CBAT
$84.9M
| $19K | ﹤0.01% |
14,275
-34,178
| -71% | -$27.1K |
2025 Q4
3 quarters
|
|
4302
Stereotaxis
STXS
$85.7M
| $17.8K | ﹤0.01% |
+14,503
| New | +$20.8K |
2026 Q3
0 quarters
|
|
4303
Nouveau Monde Graphite
NMG
$254M
| $16.9K | ﹤0.01% |
14,065
-574
| -4% | -$807 |
2026 Q2
1 quarter
|
|
4304
Gaia
GAIA
$31.8M
| $16.5K | ﹤0.01% |
12,528
-31,244
| -71% | -$52K |
2026 Q1
2 quarters
|
|
4305
Sundial Growers
SNDL
$340M
| $15.5K | ﹤0.01% |
+11,990
| New | +$15.8K |
2026 Q3
0 quarters
|
|
4306
Lantern Pharma
LTRN
$6.88M
| $15.4K | ﹤0.01% |
+15,296
| New | +$36.8K |
2026 Q3
0 quarters
|
|
4307
Biote Corp
BTMD
$29.5M
| $14.8K | ﹤0.01% |
12,269
-7,467
| -38% | -$13.2K |
2026 Q2
1 quarter
|
|
4308
Tron Inc
TRON
$683M
| $14.6K | ﹤0.01% |
+10,294
| New | +$16.1K |
2026 Q3
0 quarters
|
|
4309
IN8bio
INAB
$8.87M
| $14.4K | ﹤0.01% |
+10,836
| New | +$12.7K |
2026 Q3
0 quarters
|
|
4310
Claros Mortgage Trust
CMTG
$223M
| $13.7K | ﹤0.01% |
+10,995
| New | +$19.9K |
2026 Q3
0 quarters
|
|
4311
Cadrenal Therapeutics
CVKD
$5.39M
| $13.4K | ﹤0.01% |
+12,363
| New | +$22.4K |
2026 Q3
0 quarters
|
|
4312
Innventure Inc
INV
$13.9M
| $12.6K | ﹤0.01% |
21,987
+10,298
| +88% | +$24.5K |
2026 Q2
1 quarter
|
|
4313
ABVC BioPharma
ABVC
$26M
| $12.1K | ﹤0.01% |
+11,390
| New | +$12.7K |
2026 Q3
0 quarters
|
|
4314
Kandi Technologies Group
KNDI
$33.3M
| $11.5K | ﹤0.01% |
1,452
-1,450
| -50% | -$9.45K |
2025 Q3
4 quarters
|
|
4315
iQIYI
IQ
$862M
| $10.9K | ﹤0.01% |
10,908
-583,948
| -98% | -$651K |
2022 Q4
15 quarters
|
|
4316
Gen Digital Inc Contingent Value Rights
GENVR
| $10.4K | ﹤0.01% |
12,650
-150
| -1% | -$427 |
2025 Q2
5 quarters
|
|
4317
Opendoor Technologies Inc Series K Warrants
OPENW
$751K
| $2.73K | ﹤0.01% |
22,576
| – | – |
2025 Q4
3 quarters
|
|
|
4318
Opendoor Technologies Inc Series Z Warrants
OPENZ
$774K
| $1.8K | ﹤0.01% |
22,576
| – | – |
2025 Q4
3 quarters
|
|
|
4319
Opendoor Technologies Inc Series A Warrants
OPENL
$516K
| $1.77K | ﹤0.01% |
22,575
| – | – |
2025 Q4
3 quarters
|
|
4320
Alcoa
AA
$10.7B
| – | – |
-151,654
| Closed | -$7.23M | – |
|
4321
CALL
Agilent Technologies
A
$48.8B
| – | – |
-58,300
| Closed | -$7.74M | – |
|
4322
American Assets Trust
AAT
$1.32B
| – | – |
-21,135
| Closed | -$522K | – |
|
4323
Acumen Pharmaceuticals
ABOS
$15.8M
| – | – |
-52,351
| Closed | -$140K | – |
|
4324
CALL
Arbor Realty Trust
ABR
$239M
| – | – |
-15,100
| Closed | -$81.8K | – |
|
4325
PUT
Abivax
ABVX
$7.9B
| – | – |
-2,200
| Closed | -$293K | – |
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.